Evaluation and Management of Hyponatremia (Sodium 122 mEq/L) with Low Serum Osmolality
Immediate Assessment Priority
You must first determine the patient's volume status and symptom severity, as these dictate whether this is a medical emergency requiring hypertonic saline or a chronic condition requiring cautious correction. 1
Critical Initial Questions
- Symptom severity: Does the patient have severe neurological symptoms (seizures, coma, altered mental status, confusion)? If yes, this is a medical emergency requiring immediate 3% hypertonic saline. 1, 2
- Onset timing: Is this acute (<48 hours) or chronic (>48 hours)? Acute symptomatic hyponatremia can be corrected more rapidly without osmotic demyelination risk. 1
- Volume status: Is the patient hypovolemic (orthostatic hypotension, dry mucous membranes, decreased skin turgor), euvolemic (no edema, normal volume), or hypervolemic (peripheral edema, ascites, jugular venous distention)? 1, 3
Essential Diagnostic Workup
Order these tests immediately to guide treatment: 1, 4
- Serum osmolality (to confirm true hypotonic hyponatremia; normal is 275-290 mOsm/kg)
- Urine osmolality (>100 mOsm/kg indicates impaired water excretion)
- Urine sodium concentration (>20-40 mEq/L suggests SIADH in euvolemic patients; <30 mEq/L suggests hypovolemia)
- Serum uric acid (<4 mg/dL has 73-100% positive predictive value for SIADH)
- TSH and cortisol (to exclude hypothyroidism and adrenal insufficiency)
- Assess extracellular fluid volume status clinically (though physical exam alone has only 41% sensitivity and 80% specificity)
Treatment Algorithm Based on Symptom Severity
Severe Symptomatic Hyponatremia (Medical Emergency)
If the patient has seizures, coma, or severe altered mental status, immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours or until symptoms resolve. 1, 2
- Give 100 mL boluses of 3% saline over 10 minutes, repeatable up to 3 times at 10-minute intervals 1
- Never exceed 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome 1, 5
- Monitor serum sodium every 2 hours during initial correction 1
- Admit to ICU for close monitoring 1
Asymptomatic or Mildly Symptomatic Hyponatremia
Treatment depends entirely on volume status: 1, 3
Hypovolemic Hyponatremia (Volume Depleted)
- Administer isotonic saline (0.9% NaCl) at 15-20 mL/kg/h initially, then 4-14 mL/kg/h based on response 1
- Discontinue any diuretics immediately 1
- Urine sodium <30 mEq/L predicts good response to saline (71-100% positive predictive value) 1, 4
- Common causes: diuretics, vomiting, diarrhea, cerebral salt wasting 1
Euvolemic Hyponatremia (SIADH)
Fluid restriction to 1 L/day is the cornerstone of treatment. 1, 4, 6
- If no response to fluid restriction after 24-48 hours, add oral sodium chloride 100 mEq three times daily 1
- For resistant cases, consider vasopressin receptor antagonists (tolvaptan 15 mg once daily, titrate to 30-60 mg) 1, 5
- Tolvaptan requires hospital initiation with sodium monitoring every 2 hours for first 8 hours 5
- Avoid tolvaptan for >30 days due to hepatotoxicity risk 5
- Diagnostic criteria for SIADH: euvolemia, urine osmolality >300 mOsm/kg, urine sodium >20-40 mEq/L, normal thyroid/adrenal function 4, 6
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
- Implement fluid restriction to 1-1.5 L/day 1
- Temporarily discontinue diuretics if sodium <125 mEq/L 1
- For cirrhotic patients, consider albumin infusion (8 g per liter of ascites removed) 1
- Avoid hypertonic saline unless life-threatening symptoms present, as it worsens edema and ascites 1
- Treat underlying condition (optimize heart failure management, manage cirrhosis) 1
Critical Correction Rate Guidelines
The single most important safety principle: never exceed 8 mmol/L correction in any 24-hour period. 1, 5, 2
Standard-Risk Patients
- Target correction: 4-8 mmol/L per day
- Absolute maximum: 10-12 mmol/L in 24 hours 1
High-Risk Patients (Cirrhosis, Alcoholism, Malnutrition, Prior Encephalopathy)
- Maximum correction: 4-6 mmol/L per day, absolute ceiling 8 mmol/L in 24 hours 1
- These patients have 0.5-1.5% risk of osmotic demyelination even with careful correction 1
Special Considerations for Neurosurgical Patients
In patients with acute brain injury or subarachnoid hemorrhage, you must distinguish SIADH from cerebral salt wasting (CSW), as they require opposite treatments: 1, 4
SIADH (Euvolemic)
Cerebral Salt Wasting (Hypovolemic)
- Treat with aggressive volume and sodium replacement (50-100 mL/kg/day isotonic or hypertonic saline) 1
- Add fludrocortisone 0.1-0.2 mg daily for severe cases 1
- Never use fluid restriction in CSW—it worsens outcomes and precipitates cerebral ischemia 1
- CVP <6 cm H₂O indicates hypovolemia 1
Monitoring Protocol
During Active Correction
- Severe symptoms: Check sodium every 2 hours 1
- Mild symptoms: Check sodium every 4-6 hours 1
- After symptom resolution: Check sodium every 4-6 hours until stable, then daily 1
Watch for Osmotic Demyelination Syndrome
- Symptoms typically appear 2-7 days after rapid correction 1
- Signs: dysarthria, dysphagia, oculomotor dysfunction, quadriparesis, altered mental status 1
- If overcorrection occurs (>8 mmol/L in 24 hours), immediately stop hypertonic saline and administer D5W or desmopressin to relower sodium 1
Common Pitfalls to Avoid
- Never correct chronic hyponatremia faster than 8 mmol/L in 24 hours—this causes osmotic demyelination syndrome 1, 2
- Never use fluid restriction in cerebral salt wasting—it worsens cerebral ischemia 1
- Never use hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms—it worsens fluid overload 1
- Never ignore mild hyponatremia (130-135 mmol/L)—it increases fall risk (21% vs 5%) and mortality (60-fold increase with sodium <130 mmol/L) 1
- Never rely solely on physical examination for volume status—it has only 41% sensitivity 1
- Never use normal saline in SIADH—it can worsen hyponatremia 1, 6
Medication Review
Immediately review and discontinue or adjust these common culprits: 1, 7
- Diuretics (thiazides, loop diuretics)
- SSRIs and other antidepressants
- Carbamazepine
- NSAIDs
- Opioids
- Chemotherapy agents (platinum-based, vinca alkaloids)